Search

10 results on this page

Kling AI Raises $3 Billion as Kuaishou Splits Strategy

Kling AI Raises $3 Billion as Kuaishou Splits Strategy

Kuaishou’s Kling AI raised nearly $3 billion at a post-money valuation of $18 billion, with Kuaishou’s stake falling to 68.33% and a potential Hong Kong IPO targeted by 2031. Despite strong revenue growth, Kling faces slowing momentum, talent departures, and intense competition from ByteDance’s Seedance and open-source video models.

癌症定制疫苗首度闖過III期

癌症定制疫苗首度闖過III期

Merck與Moderna宣布,個性化腫瘤疫苗intismeran autogene在黑色素瘤III期試驗中取得陽性結果,與PD-1抑制劑聯用可顯著改善無復發生存期及無遠處轉移生存期。該療法利用患者腫瘤突變資料與AI篩選新生抗原,為每位患者製作專屬mRNA疫苗。

Page 1